Reduced Immune Activation During Tenofovir–Emtricitabine Therapy in HIV-Negative Individuals

Abstract

TFV disoproxil fumarate/FTC therapy was associated with decreased T-cell activation in HIV-negative adults, which could contribute to the antiviral effect of pre-exposure prophylaxis (NCT01040091; www.clinicaltrials.gov).